pdm08
Malignant Solid Tumours
Prodimed S.A.Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Malignant Solid Tumours cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Allogeneic Γδ T Cells Chinese PLA General Hospital | Phase 1/2 | CCC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →